Donate

PATH strives for vaccine equity in response to COVID-19

Related program: Center for Vaccine Innovation and Access

When COVID-19 emerged, we mobilized quickly and deployed our decades of experience advancing equitable access to vaccines and immunization to support the global COVID-19 response.

Through the PATH Center for Vaccine Innovation and Access (CVIA), our COVID-19 work spans the full vaccine development to delivery spectrum, including supporting country vaccine readiness; COVAX and other efforts to ensure equitable access to vaccine; vaccine development and manufacturing scale-up; vaccine clinical evaluation; immunization system resiliency; and other efforts.

CVIA and COVID-19
Featured articles
Read more
February 25, 2022
In Laos, an old partnership makes new progress against COVID-19

How PATH and the Ministry of Health are building on work against Japanese encephalitis to strengthen pandemic response.

November 1, 2021
What pneumonia can teach us about COVID-19

COVID-19 still has many unknowns, but hope lies in what we already know about preventing and treating pneumonia.

October 11, 2021
Money matters on the road to vaccine equity

PATH’s Hannah Kettler, PhD, explains how innovative financing strategies can improve global vaccine access.

September 15, 2021
Why are pregnant people left out of vaccine research?

And could COVID-19 change things moving forward?

August 11, 2021
Virus variants and vaccine efficacy

PATH scientist shares four lessons from rotavirus for SARS-CoV-2.

August 2, 2021
How do experts ensure vaccine safety?

From clinical trials to population surveillance, these are the multilevel mechanisms that ensure vaccine safety—including the safety of COVID-19 vaccines.

May 18, 2021
Classic tech meets new science: How a chicken egg could help end the pandem

The world needs more affordable and accessible COVID-19 vaccines. A new formula made in chicken eggs may be an answer.

October 11, 2021
What is COVAX?

Five key questions and answers on the global initiative to deliver COVID-19 vaccines to billions of people.

July 27, 2021
Weighing the risks and benefits of vaccines

All medical interventions carry risks and benefits. Scientists from PATH’s Center for Vaccine Innovation and Access apply insights from rotavirus to COVID-19.

July 14, 2021
What is fueling the COVID-19 crisis in Africa?

While the Delta variant is a growing concern in the United States, countries across Africa are in crisis mode as COVID-19 spreads rapidly and vaccination rates remain devastatingly low.

July 1, 2021
Africa’s third wave is killing thousands and the world is not paying ...

In some African countries the death rate has tripled in a week.

May 10, 2021
Facilitating real-world research on COVID-19 vaccines

Local vaccine studies provide critical evidence to health officials, regulators, and manufacturers alike—but only a handful of sites worldwide are equipped to run them.

April 8, 2021
NY Times says new vaccine could be "game-changer"

"A new formulation entering clinical trials...could change how the world fights the pandemic," says Times article.

March 31, 2021
What does it take to deliver COVID-19 vaccines?

Ending the COVID-19 crisis hinges on all countries being able to vaccinate their people. A lot goes into getting ready.

February 25, 2021
To optimize COVID-19 vaccine rollout, listen to health workers

Health care workers in Kenya and Zambia are helping design vaccine preparedness and distribution plans.

February 10, 2021
mRNA and the future of vaccine manufacturing

mRNA vaccine production is fast—very fast. What does that mean for traditional methods of vaccine production?

Other reading

  1. Understanding the journey to herd immunity

    With COVID-19 vaccinations underway in some countries, is herd immunity on the horizon?

  2. Striking a balance: Resuming routine immunization in India

    As the COVID-19 pandemic continues, we must adapt immunization services to protect Indian children from deadly, vaccine-preventable illnesses.

  3. When a COVID-19 vaccine is ready, will the world be?

    Vaccine feasibility is only one piece of the immunization puzzle. We need to start solving for the rest right now.

  4. 3 ways immunization data tools are flexing to fight COVID-19 in Africa

    Digital and data tools and approaches first introduced to strengthen immunization services can be used to understand and curb the devastating impacts of pandemics like COVID-19.

  5. Avoiding the “double whammy”: PATH advances immunization in the time of COVID

    COVID-19 is disrupting immunization programs in the communities that count on them most. Despite the pandemic, PATH is working to protect and continue this lifesaving service.

  6. Why the COVID-19 epidemic is not a surprise

    For researchers like Dr. Fred Cassels, who leads the Enteric and Diarrheal Diseases team at PATH’s Center for Vaccine Innovation and Access, the emergence of a new strain of coronavirus comes as no surprise.